v3.26.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net income $ 1,104 $ 5,127
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 11,137 10,406
Amortization of right-of-use assets 968 618
Amortization of debt issuance costs 47 56
Stock-based compensation 21,314 29,756
Deferred income taxes 2,438 1,996
Change in fair value of other equity security 0 (302)
Unrealized foreign exchange loss 143 76
Gain on sale of assets held for sale 0 (14,337)
Loss on disposal of property and equipment 0 99
Changes in operating assets and liabilities, net of effects of business combination:    
Accounts receivable (3,984) (9,148)
Prepaid expenses and other current assets (2,348) (2,238)
Other assets 412 204
Accounts payable 11,248 5,329
Accrued expenses and other liabilities (13,882) (3,247)
Operating lease liabilities (896) (536)
Income tax payable 7 6
Deferred revenue 19,574 26,838
Net cash provided by operating activities 47,282 50,703
Cash flows from investing activities    
Acquisition, net of cash acquired 0 (48,123)
Proceeds from sale of assets held for sale 0 37,051
Purchase of property and equipment (6,308) (9,378)
Net cash used in investing activities (6,308) (20,450)
Cash flows from financing activities    
Payment of deferred consideration from business acquisition (12,514) 0
Proceeds from issuance of stock under employee stock plans 16 43,548
Repayment of capital lease obligations 0 (2)
Repurchase of common stock (43,467) 0
Shares surrendered for settlement of minimum statutory tax withholding (4,887) (5,942)
Net cash (used in) provided by financing activities (60,852) 37,604
Effect of exchange rate changes on cash and cash equivalents (70) 52
Net (decrease) increase in cash and cash equivalents (19,948) 67,909
Cash and cash equivalents, at beginning of the period 203,100 142,064
Cash and cash equivalents, at end of the period 183,152 209,973
Non-cash operating, investing, and financing activities:    
Acquisition-related deferred consideration  101 13,058
Accrued stock repurchase excise tax 356 0
Issuance of common stock for business acquired 0 20,048
Purchase of property and equipment included in accounts payable and accrued expenses and other current liabilities 1,231 855
Capitalized stock-based compensation 1,209 1,340
Right-of-use assets obtained in exchange of operating lease liabilities (excluding right-of-use assets acquired as part of business acquisition) 1,753 3,764
Cash paid during the period for:    
Interest on deferred consideration for business acquisition $ 626 $ 0